69
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

How to assess the best immunohistochemical panel in the diagnosis of malignant pleural mesothelioma in a pathology lab

, , , , &

References

  • Galateau-Salle, F.; Churg, A.; Roggli, V.; Travis, W. D. The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification. J. Thorac. Oncol. 2016, 11(2), 142–154. DOI: 10.1016/j.jtho.2015.11.005.
  • Nicholson, A. G.; Tsao, M. S.; Travis, W. D.; Patil, D. T.; Galateau-Salle, F.; Marino, M.; et al. Eighth Edition Staging of Thoracic Malignancies. Implications for the Reporting Pathologist. Arch. Pathol. Lab. Med. [Internet]. 2017, 137(9), 1255–1261.
  • Ascoli, V.; Minelli, G.; Cozzi, I.; Romeo, E.; Carnovale Scalzo, C.; Ancona, L.; et al. Pathology Reporting of Malignant Pleural Mesothelioma First Diagnosis: A Population-Based Approach. Pathol Res Pract [Internet]. Elsevier GmbH.; 2016, 212(10), 886–892. DOI: 10.1016/j.prp.2016.07.010.
  • Husain, A. N.; Colby, T. V.; Ordóñez, N. G.; Allen, T. C.; Attanoos, R. L.; Beasley, M. B.; et al. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2017 Update of the Consensus Statement from the International Mesothelioma Interest Group. Arch. Pathol. Lab. Med. 2018, 142(1), 89–108. DOI: 10.5858/arpa.2017-0124-RA.
  • Marchevsky, A. M.; LeStang, N.; Hiroshima, K.; Pelosi, G.; Attanoos, R.; Churg, A.; et al. The Differential Diagnosis between Pleural Sarcomatoid Mesothelioma and Spindle Cell/Pleomorphic (Sarcomatoid) Carcinomas of the Lung: Evidence-Based Guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center. Hum Pathol [Internet]. Elsevier Inc.; 2017, 67, 160–168. DOI: 10.1016/j.humpath.2017.07.015.
  • Lucas, D. R.; Pass, H. I.; Madan, S. K.; Adsay, N. V.; Wali, A.; Tabaczka, P.; et al. Sarcomatoid Mesothelioma and Its Histological Mimics: A Comparative Immunohistochemical Study. Histopathology. 2003, 42(3), 270–279. DOI: 10.1046/j.1365-2559.2003.01583.x.
  • Ordonez, N. G.;. Value of Thyroid Transcription Factor-1 Immunostaining in Tumor Diagnosis: A Review and Update. Adv Anat Pathol [Internet]. 2012, 19(3), 140–151. DOI: 10.1097/PAP.0b013e318253465d.
  • Bruno, R.; Alì, G.; Fontanini, G. Molecular Markers and New Diagnostic Methods to Differentiate Malignant from Benign Mesothelial Pleural Proliferations: A Literature Review. J. Thorac. Dis. [Internet]. 2018, 10(S2), S342–52. DOI: 10.21037/jtd.2017.10.88.
  • Alì, G.; Bruno, R.; Fontanini, G. The Pathological and Molecular Diagnosis of Malignant Pleural Mesothelioma: A Literature Review. J. Thorac. Dis. [Internet]. 2018, 10(S2), S276–84. DOI: 10.21037/jtd.2017.10.125.
  • Pan, C. C.; Chen, P. C. H.; Chou, T. Y.; Chiang, H. Expression of Calretinin and Other Mesothelioma-Related Markers in Thymic Carcinoma and Thymoma. Hum Pathol. 2003, 34(11), 1155–1162. DOI: 10.1053/j.humpath.2003.07.002.
  • Taliano, R. J.; Lu, S.; Singh, K.; Mangray, S.; Tavares, R.; Noble, L.; et al. E. Calretinin Expression in High-grade Invasive Ductal Carcinoma Of The Breast Is Associated with Basal-like Subtype and Unfavorable Prognosis. Hum Pathol. 2013; 44(12), 2743–2750.
  • Klebe, S.; Brownlee, N. A.; Mahar, A.; Burchette, J. L.; Sporn, T. A.; Vollmer, R. T.; et al. Sarcomatoid Mesothelioma: A Clinical-Pathologic Correlation of 326 Cases. Mod Pathol. Nature Publishing Group. 2010, 23(3), 470–479. DOI: 10.1038/modpathol.2009.180.
  • Hida, T.; Matsumoto, S.; Hamasaki, M.; Kawahara, K.; Tsujimura, T.; Hiroshima, K.; et al. Deletion Status of P16 in Effusion Smear Preparation Correlates with that of Underlying Malignant Pleural Mesothelioma Tissue. Cancer Sci. 2015, 106(11), 1635–1641. DOI: 10.1111/cas.12769.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.